Abstract

Regenerative medicine has promise for normalizing congenital abnormalities and healing or replacing tissues and organs damaged by illness, aging, or trauma. It can prevent illnesses in a variety of organ systems and situations, as well as treat acute insults and chronic disorders. Using materials and de novo produced cells to restore missing tissue, promoting tissue recovery, or utilizing the body’s natural healing ability are some ways employed in regenerative medicine. Globally, cardiovascular disease is a serious problem due to the projected 46% rise in cases by 2030. The foundation for reconsidering therapeutic strategies and creating novel bioengineering treatments has been laid by developments in tissue engineering, stem cell engineering, functional biomaterials, and biofabrication technologies. Organoid technology is being used in regenerative medicine to produce miniature tissue models that can simulate human physiopathology and compete with widely used platforms for medication safety.